申请人:Vertex Pharmaceuticals Incorporated
公开号:US20140187772A1
公开(公告)日:2014-07-03
This invention describes novel pyrazole compounds of formula III:
wherein Z
1
, Z
2
, and Z
3
are as described in the specification; Q is —S—, —O—, —N(R
4
)—, or —CH(R
6
)—; R
1
is T-Ring D, wherein Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; and R
2
and R
2′
are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.